Cargando…
Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
BACKGROUND/AIMS: Coronavirus disease 2019 (COVID-19) is recognized to have variable clinical manifestations. The clinical presentation of patients with inflammatory bowel disease (IBD) having COVID-19 is unclear. METHODS: We identified articles reporting about the clinical presentation of COVID-19 i...
Autores principales: | Singh, Anupam K., Jena, Anuraag, Kumar-M, Praveen, Jha, Daya Krishna, Sharma, Vishal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831773/ https://www.ncbi.nlm.nih.gov/pubmed/33440918 http://dx.doi.org/10.5217/ir.2020.00108 |
Ejemplares similares
-
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis
por: Singh, Anupam Kumar, et al.
Publicado: (2021) -
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic
por: Jena, Anuraag, et al.
Publicado: (2021) -
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis
por: James, Deepak, et al.
Publicado: (2022) -
Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial
por: Jena, Anuraag, et al.
Publicado: (2020) -
Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis
por: Jena, Anuraag, et al.
Publicado: (2022)